Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA

Transplantation. 2021 Oct 1;105(10):2184-2200. doi: 10.1097/TP.0000000000003642.

Abstract

Hemodynamic instability (HDI) during liver transplantation (LT) can be difficult to manage and increases postoperative morbidity and mortality. In addition to surgical causes of HDI, patient- and graft-related factors are also important. Nitric oxide-mediated vasodilatation is a common denominator associated with end-stage liver disease related to HDI. Despite intense investigation, optimal management strategies remain elusive. In this consensus article, experts from the International Liver Transplantation Society, the Liver Intensive Care Group of Europe, and the Society for the Advancement of Transplant Anesthesia performed a rigorous review of the most current literature regarding the epidemiology, causes, and management of HDI during LT. Special attention has been paid to unique LT-associated conditions including the causes and management of vasoplegic syndrome, cardiomyopathies, LT-related arrhythmias, right and left ventricular dysfunction, and the specifics of medical and fluid management in end-stage liver disease as well as problems specifically related to portal circulation. When possible, management recommendations are made.

Publication types

  • Practice Guideline
  • Systematic Review

MeSH terms

  • Consensus
  • Fluid Therapy* / adverse effects
  • Fluid Therapy* / mortality
  • Hemodynamics*
  • Humans
  • Intraoperative Complications / etiology
  • Intraoperative Complications / mortality
  • Intraoperative Complications / physiopathology
  • Intraoperative Complications / therapy*
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / surgery*
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / mortality
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome